查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571602

美國雇主和工作場所藥物測試市場規模、佔有率、趨勢分析報告：按類型、按產品、按模式、按藥物、按最終用途、按地區、細分市場預測，2024-2030 年

U.S. Employer And Workplace Drug Testing Market Size, Share & Trends Analysis Report By Type (Pre-employment Drug Screens), By Product, By Mode, By Drug, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

美國雇主和工作場所藥物測試市場的成長和趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年美國雇主和工作場所藥物檢測市場規模將達到34.7億美元，2024年至2030年複合年成長率為5.1%。

監管合規性是市場成長的關鍵驅動力。運輸部(DOT) 和藥物濫用和心理健康服務管理局 (SAMHSA) 等聯邦法規要求對安全敏感工作進行測試，以確保職場安全並降低責任風險。這些法規要求對各個行業進行檢查，特別是那些涉及重型機械和運輸的行業。

2020年，美國公共衛生協會倡導採取綜合策略來解決鴉片類藥物使用障礙（OUD）和職業環境中的過量攝取風險，進一步強調了藥物檢測的重要性。建議包括加強傷害預防計劃、解決人體工學風險、提供鴉片類藥物濫用教育、提供同儕支持以及透過勞工賠償來規範鴉片類藥物處方。這項政策推動凸顯了對積極藥物檢測措施日益成長的需求。

為了應對這些監管和政策壓力，美國運輸部將於 2023 年 5 月敲定新法規，要求運輸部規定的藥物檢測涉及至少兩個 SAMHSA 認可的檢測實驗室，並決定允許進行口腔液檢測。這一發展凸顯了藥物測試的發展，並提高了測試程序的靈活性和準確性。透過擴大檢測選擇，新法規預計將推動對口腔液檢測解決方案的需求，使雇主和檢測提供者都受益，並支持整體市場成長。

此外，勞動力中物質使用障礙（SUD）的增加正在顯著影響美國雇主/職場藥物測試市場的成長。這些疾病的普遍存在會導致缺勤率升高、生產力降低以及工作場所事故增加。這迫使雇主實施嚴格的藥物檢測計劃，以快速識別和解決藥物濫用問題。這種積極主動的方法不僅有助於維持安全和高效的職場環境，還可以減少與殘疾員工相關的業務風險和法律責任。人們對 SUD 負面影響的認知不斷提高，推動了對更先進、更全面的藥物檢測解決方案的需求，從而促進了市場擴張。

此外，隨著組織優先考慮創造更安全的職場環境，藥物測試已成為安全計畫的重要組成部分。對與藥物濫用相關的風險（包括判斷力受損和事故率增加）的認知正在促使雇主實施強力的政策。這種對安全的重視在建設業、製造和運輸等高風險行業尤其明顯。透過識別和解決藥物濫用問題，雇主可以減少潛在危險，提高職場的整體安全性，並降低相關成本。對安全的認知和承諾的提高增加了對綜合解決方案的需求並推動了市場成長。

美國雇主和工作場所藥物檢測市場報告亮點

  • 按類型分類，離職後細分市場將在 2023 年以 80.80% 的銷售佔有率佔據市場主導地位。減少事故、工傷和相關責任的風險是美國離職後藥物檢測的關鍵驅動力。建築、運輸和製造等高風險行業的雇主敏銳地意識到殘疾員工對職場安全的危險。
  • 以產品來看，消耗品細分市場佔據主導地位，2023 年銷售佔有率為 33.42%。這部分對於確保藥物測試的準確性和可靠性至關重要，並直接影響藥物篩檢計劃的有效性。監管環境極大地影響了消費品領域，運輸部(DOT) 和藥物濫用和心理健康服務管理局 (SAMHSA) 的聯邦指導方針為藥物測試程序和相關產品製定了具體標準。
  • 從模式來看，尿液細分市場佔最大市場佔有率，2023年將達41.38%。由於尿液檢查的可靠性和易用性，它是雇主最常用的僱用前藥物測試類型。這種方法仍然是受監管和不受監管行業的主要方法，確保在各個領域的一致應用。
  • 按藥品分類，大麻/大麻細分市場在 2023 年佔據最大市場佔有率，達到 56.89%，預計在預測期內將以最快的複合年成長率成長。許多州的大麻合法化和非刑事化減少了大麻使用的恥辱，導致消費增加，包括僱員的消費。
  • 依最終用途分類，其他專業服務細分市場佔據主導地位，2023 年銷售佔有率最大，為 39.11%。美國雇主和工作場所藥物檢測的需求正在受到各種專業服務部門的推動，包括專業、技術、批發貿易和政府。
  • 兒科心臟腫瘤診斷市場的競爭非常激烈。主要企業採取各種策略，包括新產品開發、聯盟、收購和合併，以滿足客戶未滿足的需求。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章美國雇主和工作場所藥物檢測市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/補充市場展望。
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 美國雇主和工作場所藥物測試市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章美國雇主和工作場所藥物檢測市場：類型估計和趨勢分析

  • 細分儀表板
  • 美國雇主和工作場所藥物檢測市場類型變化分析
  • 2018-2030 年美國雇主及工作場所藥物檢測市場規模及趨勢分析（按類型）
  • 就業前藥物測試
  • 就業後

第5章美國雇主與工作場所藥物檢測市場：產品評估與趨勢分析

  • 細分儀表板
  • 美國雇主與工作場所藥物檢測市場產品變化分析
  • 2018-2030 年美國雇主及工作場所藥物檢測市場規模及趨勢分析（依產品）
  • 消耗品
  • 裝置
  • 快速檢測裝置
  • 服務

第6章美國雇主和工作場所藥物檢測市場：模式估計和趨勢分析

  • 細分儀表板
  • 美國雇主與工作場所藥物檢測市場模式變化分析
  • 2018-2030 年美國雇主及工作場所藥物檢測市場規模及趨勢分析（按模式）
  • 尿
  • 頭髮
  • 唾液
  • 即時測試

第7章美國雇主和工作場所藥物檢測市場：藥物估計和趨勢分析

  • 細分儀表板
  • 美國雇主與工作場所藥物檢測市場藥物波動分析
  • 2018-2030 年美國雇主及職場藥物檢測市場規模及趨勢分析（依藥物）
  • 酒精
  • 大麻/大麻
  • 古柯鹼
  • 鴉片類藥物
  • 安非他命和甲基安非他命
  • LSD
  • 其他

第8章美國雇主和工作場所藥物測試市場：最終用途估計和趨勢分析

  • 細分儀表板
  • 美國雇主和工作場所藥物測試市場的最終用途變化分析
  • 2018-2030 年美國雇主和工作場所藥物檢測市場規模和趨勢分析（按最終用途）
  • 資訊科技/金融
  • 製造業
  • 運輸
  • 建造
  • 零售和酒店業
  • 衛生保健
  • 教育
  • 其他專業服務

第9章 競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2023 年企業市場分析
  • 主要身份驗證提供者/方案所有者列表
  • 公司簡介/上市公司
    • First Advantage
    • Laboratory Corporation of America Holdings（Labcorp）
    • Dragerwerk AG &Co. KGaA
    • Bio-Rad Laboratories, Inc.
    • Abbott
    • Clinical Reference Laboratory Inc.
    • Quest Diagnostics
    • Cordant Health Solutions
    • DISA Global Solutions
    • HireRight, LLC
    • OraSure Technologies, Inc.
    • Psychemedics Corporation
    • Omega Laboratories
Product Code: GVR-4-68040-450-9

U.S. Employer And Workplace Drug Testing Market Growth & Trends:

The U.S. employer and workplace drug testing market size is anticipated to reach USD 3.47 billion by 2030, growing at a CAGR 5.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Regulatory compliance is a significant driver for market growth. Federal regulations, such as those from the Department of Transportation (DOT) and the Substance Abuse and Mental Health Services Administration (SAMHSA), mandate testing for safety-sensitive roles to ensure workplace safety and mitigate liability risks. These regulations enforce testing across industries, especially those involving heavy machinery or transportation.

In 2020, the American Public Health Association further emphasized the importance of drug testing by advocating for comprehensive strategies to address Opioid Use Disorder (OUD) and overdose risks in occupational settings. Their recommendations included strengthening injury prevention programs, addressing ergonomic risks, providing opioid misuse education, offering peer support, and regulating opioid prescriptions through workers' compensation. This policy push underscores the growing need for proactive drug testing measures.

In response to these regulatory and policy pressures, the U.S. DOT finalized new regulations in May 2023, allowing oral fluid testing for DOT-mandated drug tests, provided that at least two SAMHSA-certified laboratories are involved. This development highlights the evolving landscape of drug testing, enhancing the flexibility and accuracy of testing programs. By broadening testing options, the new regulation is expected to drive demand for oral fluid testing solutions, benefiting both employers and testing providers and supporting the overall market growth.

Additionally, the increase in substance use disorders (SUDs) among the workforce significantly impacts the growth of the U.S. employer & workplace drug testing market. The prevalence of these disorders contributes to higher rates of absenteeism, lower productivity, and increased workplace accidents. Employers are therefore compelled to implement rigorous drug testing programs to identify and address substance abuse issues promptly. This proactive approach not only helps in maintaining a safe and productive work environment but also reduces operational risks and legal liabilities associated with impaired employees. The growing recognition of the adverse effects of SUDs drives demand for more advanced and comprehensive drug testing solutions, contributing to the market's expansion.

Furthermore, as organizations prioritize creating safer work environments, drug testing becomes an essential component of their safety programs. The awareness of the risks associated with substance abuse, including impaired judgment and increased accident rates, motivates employers to implement robust policies. This focus on safety is particularly pronounced in high-risk industries such as construction, manufacturing, and transportation. By identifying and addressing substance abuse issues, employers can mitigate potential hazards, improve overall workplace safety, and reduce associated costs. The increased awareness and commitment to safety drive the demand for comprehensive solutions, fueling market growth.

U.S. Employer And Workplace Drug Testing Market Report Highlights:

  • Based on type, the post-employment segment dominated the market with a revenue share of 80.80% in 2023. Reducing the risk of accidents, workplace injuries, and associated liabilities is a crucial driver for post-employment drug testing in the U.S. Employers in high-risk industries such as construction, transportation, and manufacturing are acutely aware of the dangers posed by impaired employees to workplace safety.
  • Based on product, the consumable segment dominated the market with a revenue share of 33.42% in 2023. This segment is vital for ensuring the accuracy and reliability of drug tests, which directly impacts the effectiveness of drug screening programs. The regulatory landscape significantly influences the consumables segment, with federal guidelines from the Department of Transportation (DOT) and the Substance Abuse and Mental Health Services Administration (SAMHSA) setting specific standards for drug testing procedures and associated products.
  • Based on mode, the urine segment held the largest market share of 41.38% in 2023. Urine tests are the most common type of pre-employment drug tests used by employers, driven by their established reliability and ease of use. This method remains a staple in both regulated and non-regulated industries, ensuring consistent application across various sectors.
  • Based on drug, the cannabis/marijuana segment held the largest market share of 56.89% in 2023 and is expected to grow at the fastest CAGR over the forecast period. The legalization and decriminalization of marijuana in many states has diminished the stigma surrounding its use, leading to increased consumption, including among employees.
  • Based on end-use, the other professional services segment dominated the market with the largest revenue share of 39.11% in 2023. The demand for employer and workplace drug testing in the U.S. is driven across various professional services sectors, including Professional, Scientific and Technical, Wholesale Trade, and Public Administration industries, due to the critical nature of their work and the need for maintaining high standards of safety, compliance, and productivity.
  • The competitive scenario in the pediatric cardiac tumor diagnostic market is high. The major companies are undertaking various strategies such as new product development, collaborations, acquisitions, and mergers for serving the unmet needs of their customers.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Product Segment
    • 1.2.3. Mode Segment
    • 1.2.4. Drug Segment
    • 1.2.5. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Employer and Workplace Drug Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Employer and Workplace Drug Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Employer and Workplace Drug Testing Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Employer and Workplace Drug Testing Market Type Movement Analysis
  • 4.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Pre-employment Drug Screens
    • 4.4.1. Pre-employment drug screens market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Post-employment
    • 4.5.1. Post-employment market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Employer and Workplace Drug Testing Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Employer and Workplace Drug Testing Market Product Movement Analysis
  • 5.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Consumables
    • 5.4.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Instruments
    • 5.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Rapid Testing Devices
    • 5.6.1. Rapid testing devices market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Services
    • 5.7.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Employer and Workplace Drug Testing Market: Mode Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Employer and Workplace Drug Testing Market Mode Movement Analysis
  • 6.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Mode, 2018 to 2030 (USD Million)
  • 6.4. Urine
    • 6.4.1. Urine market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Hair
    • 6.5.1. Hair market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Oral Fluid
    • 6.6.1. Oral fluid market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Instant testing
    • 6.7.1. Instant testing market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. U.S. Employer and Workplace Drug Testing Market: Drug Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Employer and Workplace Drug Testing Market Drug Movement Analysis
  • 7.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Drug, 2018 to 2030 (USD Million)
  • 7.4. Alcohol
    • 7.4.1. Alcohol market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Cannabis/Marijuana
    • 7.5.1. Cannabis/marijuana market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Cocaine
    • 7.6.1. Cocaine market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Opioids
    • 7.7.1. Opioids testing market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Amphetamine & Methamphetamine
    • 7.8.1. Amphetamine & methamphetamine market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. LSD
    • 7.9.1. LSD market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.10. Others
    • 7.10.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. U.S. Employer and Workplace Drug Testing Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Employer and Workplace Drug Testing Market End Use Movement Analysis
  • 8.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. IT/Finance
    • 8.4.1. IT/finance market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Manufacturing
    • 8.5.1. Manufacturing market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Transportation
    • 8.6.1. Transportation market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Construction
    • 8.7.1. Construction market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Retail and Hospitality
    • 8.8.1. Retail and hospitality market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. Healthcare
    • 8.9.1. Healthcare market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.10. Education
    • 8.10.1. Education surgical centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.11. Other Professional Services
    • 8.11.1. Other Professional Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. List of Key Certification Providers/Scheme Owners
  • 9.5. Company Profiles/Listing
    • 9.5.1. First Advantage
      • 9.5.1.1. Company overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Laboratory Corporation of America Holdings (Labcorp)
      • 9.5.2.1. Company overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Dragerwerk AG & Co. KGaA
      • 9.5.3.1. Company overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Bio-Rad Laboratories, Inc.
      • 9.5.4.1. Company overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Abbott
      • 9.5.5.1. Company overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Clinical Reference Laboratory Inc.
      • 9.5.6.1. Company overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Quest Diagnostics
      • 9.5.7.1. Company overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Cordant Health Solutions
      • 9.5.8.1. Company overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. DISA Global Solutions
      • 9.5.9.1. Company overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. HireRight, LLC
      • 9.5.10.1. Company overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. OraSure Technologies, Inc.
      • 9.5.11.1. Company overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. Psychemedics Corporation
      • 9.5.12.1. Company overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. Omega Laboratories
      • 9.5.13.1. Company overview
      • 9.5.13.2. Financial performance
      • 9.5.13.3. Product benchmarking
      • 9.5.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 U.S. employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 3 U.S. employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 4 U.S. employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 5 U.S. employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 6 U.S. employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 U.S. employer and workplace drug testing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 U.S. employer and workplace drug testing market: Type outlook key takeaways
  • Fig. 20 U.S. employer and workplace drug testing market: Type movement analysis
  • Fig. 21 Pre-employment drug screens market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Post-employment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. employer and workplace drug testing market: Product outlook key takeaways
  • Fig. 24 U.S. employer and workplace drug testing market: Product movement analysis
  • Fig. 25 Consumables market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Rapid testing devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. employer and workplace drug testing market: Mode outlook key takeaways
  • Fig. 30 U.S. employer and workplace drug testing market: Mode movement analysis
  • Fig. 31 Urine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Hair market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Oral fluid market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Instant testing estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. employer and workplace drug testing market: Mode outlook key takeaways
  • Fig. 36 U.S. employer and workplace drug testing market: Mode movement analysis
  • Fig. 37 Alcohol market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Cannabis/marijuana market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Cocaine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Opioids estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Amphetamine & methamphetamine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 LSD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. employer and workplace drug testing market: End use outlook key takeaways
  • Fig. 45 U.S. employer and workplace drug testing market: End use movement analysis
  • Fig. 46 IT/finance market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Transportation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Construction estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Retail and hospitality market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Healthcare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Education market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Other professional services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Market participant categorization
  • Fig. 55 U.S. employer and workplace drug testing market position analysis, 2023
  • Fig. 56 Strategic framework